BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17936067)

  • 21. Heart failure: recent advances in prevention and treatment.
    Fonarow GC
    Rev Cardiovasc Med; 2000; 1(1):25-33, 54. PubMed ID: 12457149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug treatment for chronic systolic heart failure.
    Mörike K; Sindermann JR
    Thorac Cardiovasc Surg; 2010 Feb; 58 Suppl 2():S170-2. PubMed ID: 20101534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey.
    Komajda M; Lapuerta P; Hermans N; Gonzalez-Juanatey JR; van Veldhuisen DJ; Erdmann E; Tavazzi L; Poole-Wilson P; Le Pen C
    Eur Heart J; 2005 Aug; 26(16):1653-9. PubMed ID: 15827061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular basis for therapeutic choices in heart failure.
    Opie LH
    Circulation; 2004 Oct; 110(17):2559-61. PubMed ID: 15505109
    [No Abstract]   [Full Text] [Related]  

  • 25. The HF epidemic: the need for new treatment strategies.
    Carson PE
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S32-4. PubMed ID: 17199218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Triple/quadruple therapy in heart failure: integrating scientific evidence with clinical reasoning].
    Sinagra G; Sabbadini G; Zecchin M; Di Lenarda A
    G Ital Cardiol (Rome); 2007 Sep; 8(9):559-67. PubMed ID: 17972425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An approach to heart failure and diabetes mellitus.
    Fonarow GC
    Am J Cardiol; 2005 Aug; 96(4A):47E-52E. PubMed ID: 16098844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacologic treatment of heart failure in the elderly].
    Erdmann E
    Dtsch Med Wochenschr; 2013 Apr; 138(14):700-2. PubMed ID: 23533033
    [No Abstract]   [Full Text] [Related]  

  • 29. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
    Azadpour M; Lamas GA
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic heart failure.
    Poole-Wilson PA
    Timely Top Med Cardiovasc Dis; 2007 Jan; 11():E2. PubMed ID: 18297148
    [No Abstract]   [Full Text] [Related]  

  • 31. Diastolic heart failure: state of the science on best treatment practices.
    Reddersen LA; Keen C; Nasir L; Berry D
    J Am Acad Nurse Pract; 2008 Oct; 20(10):506-14. PubMed ID: 19128346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Heart failure associated with ischemic cardiomyopathy].
    Ogawa T
    Nihon Rinsho; 2007 May; 65 Suppl 5():413-20. PubMed ID: 17571414
    [No Abstract]   [Full Text] [Related]  

  • 33. Optimal management of chronic heart failure in patients with chronic kidney disease.
    Zachariah D; Kalra PA; Kalra PR
    J Ren Care; 2009 Mar; 35(1):2-10. PubMed ID: 19200271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacological treatment of heart failure: are we looking at the sunset of the neurohormonal hypothesis.
    Porcu M
    Ital Heart J; 2002 Jul; 3(7):437-8. PubMed ID: 12189976
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chronic heart failure treatment in the year 2006].
    De Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2006; 123(3):617-30. PubMed ID: 17451101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Medical management of chronic systolic heart failure].
    Galinier M
    Rev Prat; 2010 Sep; 60(7):941-6. PubMed ID: 21033491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving outcomes in post-acute myocardial infarction heart failure: incorporation of aldosterone blockade into combination therapy to optimize neurohormonal blockade.
    Pitt B; Fonarow GC; Gheorghiade M; Deedwania PC; Duprez DA
    Am J Cardiol; 2006 May; 97(10A):26F-33F. PubMed ID: 16698332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart failure.
    McKelvie R
    Clin Evid; 2006 Jun; (15):118-39. PubMed ID: 16973007
    [No Abstract]   [Full Text] [Related]  

  • 39. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.
    Lenzen MJ; Boersma E; Reimer WJ; Balk AH; Komajda M; Swedberg K; Follath F; Jimenez-Navarro M; Simoons ML; Cleland JG
    Eur Heart J; 2005 Dec; 26(24):2706-13. PubMed ID: 16183692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment.
    Andersson B; Kjörk E; Brunlöf G
    Int J Cardiol; 2005 Oct; 104(3):257-63. PubMed ID: 16186053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.